UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
October 30, 2007
Date of Report (Date of Earliest Event Reported)
ALLERGAN, INC.
(Exact Name of Registrant as Specified in its Charter)
| |
|
|
|
|
| Delaware
|
|
1-10269
|
|
95-1622442 |
| (State of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification Number) |
2525 Dupont Drive
Irvine, California 92612
(Address of Principal Executive Offices) (Zip Code)
(714) 246-4500
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
| |
|
|
¨
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
¨
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
¨
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
|
|
|
¨
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
TABLE OF CONTENTS
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On October 30, 2007, the Board of Directors (the “Board”) of Allergan, Inc. (“Allergan”)
approved and adopted the Sixth Amendment (the “Amendment”) to Allergan’s Bylaws. In compliance with the New York Stock Exchange’s requirement that all listed securities
be eligible to participate in the Direct Registration System no later than January 1, 2008, the
Amendment allows for the issuance, recordation and transfer of the Company’s securities by
electronic or other means not involving the issuance of a certificate. The Amendment took effect
upon adoption by the Board.
The foregoing description of the Amendment is qualified in its entirety by reference to the
full text of the Amendment, a copy of which is attached hereto as Exhibit 3.1 and incorporated
herein by reference.
Item 9.01. Financial Statements and Exhibits.
| 3.1 |
|
Sixth Amendment to Allergan, Inc. Bylaws |